Viking Therapeutics Announces Proposed Public Offering of Common Stock
Go back to Viking Therapeutics Announces Proposed Public Offering of Common Stock| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 33.67 +0.89 (2.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.78 | 52 Week High | $5.17 | |||
| Open | $32.61 | 52 Week Low | $0.94 | |||
| Day High | $33.71 | P/E | N/A | |||
| Day Low | $32.38 | EPS | $0.00 | |||
| Volume | 1,677,066 | |||||
